Telix Pharmaceuticals to Release Full Year 2025 Results and Host Investor Webcast on February 20, 2026.

martes, 3 de febrero de 2026, 4:37 pm ET1 min de lectura
TLX--

Telix Pharmaceuticals will release its full-year results for 2025 on February 20, 2026. An investor webcast and conference call will be held at 9:30 a.m. AEDT, with participants registering at this link: https://edge.media-server.com/mmc/p/famdpwzh. Telix is a biopharmaceutical company developing therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Visit www.telixpharma.com for more information.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios